treat your cattle bacterial diseases with the Broad-Spectrum Efficacy of Marbocyl 2%!
it is a cattle antibiotic used for treating respiratory infections caused by a wide range of gram +ve and gram -ve bacteria.
COMPOSITION
Active ingredient(s) and other ingredients: 1 ml injection of solution contains: Active ingredient: Marbofloxacin: 20.0 mg
Other ingredients whose knowledge is necessary for the appropriate administration of the product: Sodium edetate: 0.1 mg 3-Sulfanylpropane-1,2-diol: 0.5 mg Metacresol: 2.0 mg . Marbocyl 2% is packaged in amber type II glass vials of 100 mlS.C and 1.V. in pre-ruminant calves up to 100 kg b.w
indications:
FOR USE IN PRE-RUMINATING CALVES UP TO 100 KG B.W. MARBOCYL 2% is indicated in the treatment of respiratory infections caused by susceptible strains of organisms.
dosage and administration:
The daily dose is 2 mg marbofloxacin per kg, thus a subcutaneous or intramuscular injection of 1 ml per 10 kg body weight once daily for 3-5 days. The first injection can also be administered iv.
Pharmacodynamic properties:
Marbofloxacin is a synthetic bactericidal anti-infective belonging to the group of fluoroquinolones.
It acts by inhibiting DNA gyrase. Its broad spectrum of activity includes: Gram-positive bacteria (mainly staphylococci)
Gram-negative bacteria: (Escherichia coli, Pasteurella multocida, Mannheimia (Pasteurella) haemolytica and Actinobacillus pleuropneumonia) as well as mycoplasmas (Mycoplasma bovis, Mycoplasma hyo pneumoniae).
Resistance may occur in streptococci.
side effects:
Subcutaneous and intramuscular injection can cause temporary edema at the injection site.
Intramuscular injection can cause pain reactions and inflammatory changes at the injection site.
These remain detectable for 12 days in calves.
If you notice any side effects in your animal/animals that are not listed in the package leaflet, please inform your veterinarian or pharmacist.
Special warnings:
Special precautions for use in animals:
It is recommended that fluoroquinolones be used for therapeutic purposes only if other groups of antibiotics have been ineffective or are likely to be insufficiently effective.
The use of fluoroquinolones should, if possible, be based on a susceptibility test (antibiogram). When using the veterinary medicinal product, the official and local regulations on the use of antibiotics must be taken into account.
Deviations from the conditions of use stated in the package and specialist information can increase the prevalence of fluoroquinolone-resistant bacteria and, due to possible cross-resistance, reduce the effectiveness of treatment with other quinolones.
Use during pregnancy, lactation or the laying period: Studies on laboratory animals (rats, rabbits) have shown no teratogenic, embryotoxic or materno toxic effects of marbofloxacin.
The use is therefore at the discretion of the attending veterinarian after assessing the benefit-risk ratio. See also withdrawal period.
Overdose (symptoms, emergency procedures and antidotes), if necessary:
No symptom of overdose was observed after administration of marbofloxacin at three times the recommended dose. The symptoms of overdose with marbofloxacin are of the acute neurological type and are treated symptomatically.
withdrawal periods:
CATTLE Calves and young cattle: Edible tissue: 6 days
STORE:
STORE IT BELOW 25’C AND PROTECT FROM LIGHT
Reviews
There are no reviews yet.
Be the first to review “Marbocyl 2% | marbofloxacin | for respiratory infection in cattle” Cancel reply
Reviews
There are no reviews yet.